-
Consumers and insurers charged that Mylan, Pfizer and other companies engaged in an illegal scheme to monopolize the EpiPen market by hiking the device’s price from $100 to $600.
-
Health care spending is growing a lot faster than inflation and per-capita income. But it's not because we're getting tons more care. It's because prices rise so fast.
-
One of America's richest companies will pay nearly $30 million to the state of Kansas for allegedly overcharging Medicaid for pharmaceuticals. Also, some towns in the Midwest are offering free land or $15,000 no-strings-attached checks to attract new residents.
-
Kansas Attorney General Derek Schmidt says Centene kept Kansas in the dark about drug discounts and used other strategies to squeeze more profit out of the state's Medicaid program.
-
Emails between an auditing firm and Kansas show how quickly the state bent to the company’s wishes to keep information out of public view. Experts say this reflects a disturbing national trend.
-
Law professors who reviewed the redacted content for the Kansas News Service struggled to understand why the state would consider it legal to black out the information.
-
Kansas taxpayers and state employees could be paying too much for prescription drugs, but a state-commissioned report doesn't actually say if customers got a bargain or got gouged. Kansas even tried to black out large swaths of the audit, but it botched many of the redactions.
-
Taxpayers and state employees could be paying too much for medications. Experts say a 16-page audit commissioned by Kansas doesn't dig in to find out.
-
A state agency said its redactions shield trade secrets. But the text below the black remained readable. So we took it to experts in antitrust and public records law.
-
Being a middleman in the $1 trillion pharmaceutical industry is big business. The middlemen can even earn more than the drugmakers on prescription drugs.